NATIONAL

Shkreli Ordered To Return $64M, Is Barred From Drug Industry

0
FILE - Former Turing Pharmaceuticals CEO Martin Shkreli attends the House Committee on Oversight and Reform Committee hearing on Capitol Hill in Washington, Feb. 4, 2016. A federal judge on Friday, Jan. 14, 2022 ordered Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life. (AP Photo/Susan Walsh, File)

(AP) — A federal judge has ordered Martin Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life.

The ruling Friday by U.S. District Judge Denise Cote in New York came several weeks after a seven-day bench trial in December.

The Federal Trade Commission and seven states brought the case in 2020 against the man dubbed in the media as “Pharma Bro” in 2020. Shkreli’s lawyer did not immediately respond to a request for comment.

 

Garbage And Recyclables Pile Up As Omicron Takes Its Toll

Previous article

Goodbye ‘godsend’: Expiration Of Child Tax Credits Hits Home

Next article

You may also like

More in NATIONAL